| Literature DB >> 33619082 |
Simone M Brändle1, Manuela Cerina2, Susanne Weber1, Kathrin Held3,4, Amélie F Menke2, Carmen Alcalá5, David Gebert1, Alexander M Herrmann2, Hannah Pellkofer1, Lisa Ann Gerdes1, Stefan Bittner6, Frank Leypoldt7,8, Bianca Teegen9, Lars Komorowski10, Tania Kümpfel1, Reinhard Hohlfeld1,11, Sven G Meuth12, Bonaventura Casanova5, Nico Melzer2, Eduardo Beltrán1, Klaus Dornmair13,11.
Abstract
Encephalitis associated with antibodies against the neuronal gamma-aminobutyric acid A receptor (GABAA-R) is a rare form of autoimmune encephalitis. The pathogenesis is still unknown but autoimmune mechanisms were surmised. Here we identified a strongly expanded B cell clone in the cerebrospinal fluid of a patient with GABAA-R encephalitis. We expressed the antibody produced by it and showed by enzyme-linked immunosorbent assay (ELISA) and immunohistochemistry that it recognizes the GABAA-R. Patch-clamp recordings revealed that it tones down inhibitory synaptic transmission and causes increased excitability of hippocampal CA1 pyramidal neurons. Thus, the antibody likely contributed to clinical disease symptoms. Hybridization to a protein array revealed the cross-reactive protein LIM-domain-only protein 5 (LMO5), which is related to cell-cycle regulation and tumor growth. We confirmed LMO5 recognition by immunoprecipitation and ELISA and showed that cerebrospinal fluid samples from two other patients with GABAA-R encephalitis also recognized LMO5. This suggests that cross-reactivity between GABAA-R and LMO5 is frequent in GABAA-R encephalitis and supports the hypothesis of a paraneoplastic etiology.Entities:
Keywords: GABA-A-receptor encephalitis; autoantibody; autoimmune encephalitis; epilepsy; paraneoplastic encephalitis
Year: 2021 PMID: 33619082 PMCID: PMC7936355 DOI: 10.1073/pnas.1916337118
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205